BioAtla
BCAB
82 hedge funds and large institutions have $51.3M invested in BioAtla in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 12 closing their positions.
600% more call options, than puts
Call options by funds: $119K | Put options by funds: $17K
0.08% less ownership
Funds ownership: 1.34% → 1.26% (-0.08%)
3% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 29
6% less funds holding
Funds holding: 87 → 82 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
47% less capital invested
Capital invested by funds: $96.1M → $51.3M (-$44.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$579K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$517K |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$381K |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
+$381K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$266K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.57M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.05M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$580K |
| 4 |
Millennium Management
New York
|
-$490K |
| 5 |
O
OrbiMed
New York
|
-$374K |
BCAB Hedge Fund Activity: Q3 2023 in Review
82 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q3 2023, worth a combined $51.3M — down 47% from $96.1M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of BCAB and 7 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 28 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $579K. The largest seller was Wasatch Advisors, cutting an estimated $2.57M.
- 82 institutional investors held BioAtla (BCAB) as of Q3 2023, down from 87 in Q2 2023.
- Funds reported $51.3M of BioAtla stock for Q3 2023, down 47% quarter-over-quarter.
- 7 funds opened new BioAtla positions in Q3 2023 and 12 closed out, a net change of -5 holders.
- The largest BioAtla buyer in Q3 2023 was Dimensional Fund Advisors, an estimated $579K added.
- The largest BioAtla seller in Q3 2023 was Wasatch Advisors, an estimated $2.57M sold.
Based on aggregated 13F filings for Q3 2023.